Cancers in Australia in 2010 attributable to infectious agents
- PMID: 26437730
- PMCID: PMC4606775
- DOI: 10.1111/1753-6405.12445
Cancers in Australia in 2010 attributable to infectious agents
Abstract
Objectives: To estimate the proportion and numbers of cancers in Australia in 2010 attributable to infectious agents.
Methods: The population attributable fraction (PAF) and number of cancers caused by hepatitis B and C viruses (HBV, HCV), Helicobacter pylori and human immunodeficiency virus (HIV) were calculated using standard formulae incorporating prevalence of infection in the Australian population, the relative risks associated with that infection and cancer incidence. For cancers with very strong associations to the infectious agent (Epstein-Barr virus [EBV], human papillomavirus [HPV] and HIV/Kaposi's sarcoma herpes virus [KSHV]), calculations were based on viral prevalence in the tumour.
Results: An estimated 3,421 cancers (2.9% of all cancers) in Australia in 2010 were attributable to infections. Infectious agents causing the largest numbers of cancers were HPV (n=1,706), H. pylori (n=793) and HBV/HCV (n=518). Cancer sites with the greatest number of cancers caused by infections were cervix (n=818), stomach (n=694) and liver (n=483). Cancers with highest proportions attributable to infectious agents were Kaposi's sarcoma (100%), cervix (100%), nasopharynx (87%), anus (84%) and vagina (70%).
Conclusions: Infectious agents cause more than 3,000 cancers annually in Australia.
Implications: Opportunities for cancer prevention through infection control are considerable, even in a 'first world' nation like Australia.
Keywords: cancer; infection; population attributable fraction; risk factor.
© 2015 The Authors.
References
-
- International Agency for Research on Cancer Working Group on the Evaluation of Carcinogenic Risks to Humans. A Review of Human Carcinogens. Lyon (FRC): World Health Organisation; 2012. IARC Monographs on the Evaluation of Carcinogenic Risks to Humans. Biological Agents. Volume 100 B.
-
- de Martel C, Ferlay J, Franceschi S, Vignat J, Bray F, Forman D, et al. Global burden of cancers attributable to infections in 2008: A review and synthetic analysis. Lancet Oncol. 2012;13(6):607–15. - PubMed
-
- Hillman RJ, Garland SM, Gunathilake MP, Stevens M, Kumaradevan N, Lemech C, et al. Human papillomavirus (HPV) genotypes in an Australian sample of anal cancers. Int J Cancer. 2014;135(4):996–1001. - PubMed
-
- Hong AM, Grulich AE, Jones D, Lee CS, Garland SM, Dobbins TA, et al. Squamous cell carcinoma of the oropharynx in Australian males induced by human papillomavirus vaccine targets. Vaccine. 2010;28(19):3269–72. - PubMed
-
- Antonsson A, Neale RE, Boros S, Lampe G, Coman WB, Pryor DI, et al. Human papillomavirus status and p16(INK4A) expression in patients with mucosal squamous cell carcinoma of the head and neck in Queensland, Australia. Cancer Epidemiol. 2015;39(2):174–81. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical